HB1610
(Title) establishing the manufacturer pharmaceutical drug take-back program.
Bill Versions
Amendments
None
Committee Reports
BodyDocket Description
H Introduced 01/08/2020 and referred to Health, Human Services and Elderly Affairs HJ 1 P. 28
H Public Hearing: 01/30/2020 10:45 am LOB 205
H Subcommittee Work Session: 02/18/2020 10:00 am LOB 205
H Executive Session: 03/03/2020 10:00 am LOB 205
H Committee Report: Refer for Interim Study for 03/11/2020 (Vote 20-0; CC) HC 10 P. 20
HRefer for Interim Study: MA VV 03/11/2020 HJ 7 P. 34
H Full Committee Work Session: 09/03/2020 02:00 pm Members of the public may attend using this link: https://www.zoom.us/j/93480617681 - Executive Session to Follow
HInterim Study Report: Not Recommended for Future Legislation (Vote 19-0)